Applications of 1-Boc-4-(2-Carboxyphenyl)Piperazine in Industrial Manufacturing

1-Boc-4-(2-Carboxyphenyl)Piperazine serves as a critical building block in advanced industrial chemistry. As a manufacturer, we support specialized sectors that require high-purity intermediates for synthesis, especially in regulated and performance-driven environments. Below, we detail its main industrial applications and specific integration points across four key downstream scenarios.

1. Pharmaceutical Active Pharmaceutical Ingredient (API) Intermediate Synthesis

This compound functions as a protected and functionalized piperazine derivative, widely adopted by proprietary and generic drug manufacturers for the construction of complex heterocyclic cores. In multi-stage API synthesis, formulators use this raw material to introduce both carboxy and piperazine units with orthogonal protection. It allows selective deprotection and further coupling, essential for targeted oncology and CNS drug pipelines.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• 21 CFR Part 211 (US FDA cGMP regulations for finished pharmaceuticals)
• EU Good Manufacturing Practice (EudraLex Volume 4)
• Relevant USP, Ph. Eur. monograph alerts for intermediates

Typical usage ratio

• 10–25% molar equivalent in condensation or substitution reactions; percentage adjusted per downstream yield optimization and impurity profile

Downstream process integration

• Feeds into mid-stage API intermediate construction via amide coupling or Suzuki-Miyaura cross-coupling
• Acts as a late-stage functionalization partner for advanced scaffold assembly
• Incorporated during key carbon–carbon or carbon–nitrogen bond formations
• Handles selective Boc group cleavage as the next synthesis step

Final product types

• Small-molecule oncology drugs targeting protein kinases
• Central nervous system disorder medications
• Anti-viral and anti-bacterial agents under FDA/EMA clinical review
• Custom NCEs (new chemical entities) for proprietary pipelines

2. Chemical Probe and High-Throughput Screening (HTS) Library Synthesis

Specialty research chemical and biotechnology companies integrate this piperazine derivative into novel fragment-based screening libraries. Its carboxy and protected amine groups enable combinatorial diversification and high-yield construction of bioactive scaffolds. The material's design allows for sequential modification, facilitating SAR (structure-activity relationship) profiling and lead discovery programs.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• NIST SP 260-181 Traceability Standards (chemical reference materials)
• Internal biopharma supplier QC protocols (HPLC purity, NMR traceability)
• Sigma-Aldrich and Merck raw material documentation requirements

Typical usage ratio

• 5–20 μmol per synthetic entry in parallel synthesis modules; loading varies with fragment library scale

Downstream process integration

• Introduced as a core fragment in split-pool or iterative parallel synthesis
• Used with solid-phase and solution-phase techniques for scaffold generation
• Rapidly diversified via coupling, alkylation, or functional group modification
• Purity and identity verified by high-throughput LC–MS

Final product types

• Chemical probe molecules for target validation
• Diverse HTS fragment libraries for big pharma research
• Lead-like small molecules for agrochemical discovery
• Diagnostic and imaging agent precursors

3. Custom Peptide and Peptidomimetic Synthesis

Peptide manufacturers employ this raw material to introduce non-natural, conformationally restricted motifs into peptide chains. Its orthogonally protected structure supports Fmoc or Boc-based solid-phase peptide synthesis (SPPS), directly enhancing peptide stability, targeting, or pharmacokinetics. This derivative's unique carboxyphenyl moiety increases solubility and structural diversity.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• Peptide Therapeutic Consortium quality guidelines
• Synthetic peptide cGMP guidelines (FDA, EMA)
• ISO 13485:2016 (for diagnostic peptides)

Typical usage ratio

• Incorporated as 1–3 residues per 10–50 amino acid peptide fragment; dependent on design of peptidomimetic backbone

Downstream process integration

• Loaded as a protected building block during solid-phase chain elongation
• Allows stepwise selective deprotection and on-resin modifications
• Utilized in orthogonal cyclization or bioconjugation steps
• Purified via semi-preparative HPLC after cleavage

Final product types

• Therapeutic peptides for oncology and infectious disease
• Peptidomimetic lead compounds for oral drug candidates
• Biosensor binding elements for diagnostics
• Peptide–drug conjugate scaffolds

4. Specialty Polymer and Resin Component Synthesis

Advanced material manufacturers use this compound in niche polymerization reactions, particularly where introduction of functionalized, aromatic piperazine moieties provides custom mechanical or chemical properties. The compound acts as a functional monomer precursor in step-growth and chain-growth polymerizations, supporting tunable hydrophilicity, flexibility, or thermal resistance.

Industry compliance standards

• ISO 9001:2015 for polymer batch manufacturing
• ASTM D883 Terminology for Plastics Standards
• REACH Regulation (EC 1907/2006) for chemicals in polymers
• RoHS Directive for electronics-grade resins

Typical usage ratio

• 2–8% by weight in resin formulations or copolymer blends; amount is tailored for targeted polymer property enhancement

Downstream process integration

• Feeds into step-growth polymerization as a co-monomer
• Reacted with diacid or diamine partners for chain extension
• Incorporates via melt-polymerization or solution polymerization
• Controls branching, cross-linking, or functional group densities

Final product types

• Functionalized epoxy and polyurethane resins for adhesives
• Custom medical-grade hydrogels
• Engineer-grade specialty plastics
• High-performance coatings with improved chemical resistance